He (Vivian) LIU’s Post

View profile for He (Vivian) LIU, graphic

Healthtech Innovation | Healthcare Collaboration | China Market Entry | China KOLs | Strategic Partnerships | Medical Devices & Laboratory Supplies Sourcing from China

New Insights in #Stroke Treatment! The #ANGELREBOOT trial, a comprehensive study across 36 hospitals in #China, examined the effectiveness of adding #angioplasty or #stenting after #thrombectomy for #largevesselocclusion (#LVO) strokes. Conducted from December 2021 to March 2023, the trial included 348 patients. The results, published in The Lancet Neurology on June 21, 2024, showed no significant improvement in patient outcomes at 90 days and highlighted increased risks, including symptomatic #intracranialhemorrhage and #arterialdissection. Less is more! Despite the promising potential of these #bailoutprocedures, standard therapy remains the safer choice for now. Continued research and #clinicaltrials are essential to refining stroke treatment strategies. #Neurointervention #Neurovascular #Neurosurgery #Neuroradiology #Neurosurgeons #StrokeResearch #NeuroHealth #StrokeTreatment #Neuroscience #HealthcareInnovation #PatientSafety

To view or add a comment, sign in

Explore topics